MedTrace Logo

Enhanced Multicomponent Proactive Navigator-Assisted Cessation of Tobacco Use in Low-Income Patients

NCT05750537 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13496

Last updated 2024-02-07

No results posted yet for this study

Summary

This research study is being conducted to test the effectiveness of the Enhanced Multicomponent Proactive Navigator-Assisted Cessation of Tobacco Use (EMPACT-Us), an innovative suite of tobacco cessation services designed in partnership with patients, providers, and other community stakeholders during a pilot study.

We hypothesize that EMPACT-Us will be more effective than the newly-enhanced usual care on improving engagement in tobacco treatments, quit attempts and biochemically verified cessation at 6-and 12-months post initial offerings.

Conditions

  • Tobacco Use Cessation

Interventions

BEHAVIORAL

EMPACT-Us

A suite of tobacco cessation services supported by patient navigation designed in close partnership with patients, providers, and community stakeholders.

Sponsors & Collaborators

Principal Investigators

  • David Strong, BA, MS, PhD · University of California, San Diego

  • Karim Ghobrial-Sedky, MD, MSc, DFAPA · Family Health Centers of San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-27
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05750537 on ClinicalTrials.gov